Orange Book product · Generic (ANDA)
CEFACLOR
CEFACLOR
At a glance
Feb 17, 2012
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Feb 17, 2012
14 yr 7 mo ago
Today
Pharmaceutical detail
Active ingredient
CEFACLOR
Strength
EQ 375MG BASE/5ML
Dosage form
FOR SUSPENSION
Route
ORAL
TE code
Not listed
Application
ANDA 065412
Product number
004
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
Yes
Active-ingredient family
View full familyGeneric (ANDA) of CEFACLOR
- 1996CECLOR CDBrand (NDA)
NDA 050673 · LILLY
- —CECLORBrand (NDA)
NDA 050521 · LILLY
- —CECLORBrand (NDA)
NDA 050522 · LILLY
- 2007CEFACLORGeneric (ANDA)
ANDA 065350 · HIKMA
- 2004CEFACLORGeneric (ANDA)
ANDA 065146 · YUNG SHIN PHARM
- 2003RANICLORGeneric (ANDA)
ANDA 065092 · RANBAXY LABS LTD
- 2002CEFACLORGeneric (ANDA)
ANDA 065058 · TEVA
- 2001CEFACLORGeneric (ANDA)
ANDA 065057 · WORLD GEN
- 1998CEFACLORGeneric (ANDA)
ANDA 064204 · WATSON LABS INC
- 1998CEFACLORGeneric (ANDA)
ANDA 064205 · WATSON LABS INC
- 1998CEFACLORGeneric (ANDA)
ANDA 064206 · WATSON LABS INC
- 1998CEFACLORGeneric (ANDA)
ANDA 064207 · WATSON LABS INC
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
